Similarly, the myelin oligodendrocyte glycoprotein (MOG) gene, another important myelin gene, has previously been described to be demethylated in serum from patients with MS with an active and symptomatic disease course, probably reflecting oligodendrocyte cell loss during these stages of the disease [19]. This evidence concerns the gene MOG and myeloid sarcoma.